Transplantectomie : indications et techniques chirurgicales. Recommandations de l’Association française d’urologie et de la Société francophone de transplantation
A. Frontczak(Centre Hospitalier Universitaire de Besançon), T. Culty(Centre Hospitalier Universitaire d'Angers), F. Kleinclauss(Centre Hospitalier Universitaire de Besançon), Thomas Prudhomme(Société Francophone du Diabète), Yanish Soorojebally(Université de Versailles Saint-Quentin-en-Yvelines), Cyril Garrouste(Centre Hospitalier Universitaire de Clermont-Ferrand), Arnaud Del Bello(Hôpital Rangueil), Emmanuel Morelon(Lyon 1 Université), Emilien Seizilles de Mazancourt(Hôpital Saint-Louis), A. Goujon(Centre Hospitalier Universitaire de Rennes), P. Delpech(Centre Hospitalier Universitaire de Poitiers), Brigitte Thevenin-Lemoine(Skin Research Center), Nicolas Piffault(Renault (France)), Myriam Pastural(Agence de la Biomédecine), D. Kassab(Association Française de Chirurgie), Albane Brodin-Sartorius(Assistance Publique – Hôpitaux de Paris)
Cited by 0
Related Papers
2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection
|American Journal of Transplantation|2016|631
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†
|European Urology|2020|89
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy
|British Journal of Urology|2023|64
Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic review
|World Journal of Urology|2023|42
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients
|Urologic Oncology Seminars and Original Investigations|2021|39